Apria, Inc. Stock: price and insider trades · United States

Apria, Inc. is a U.S. home healthcare and durable medical equipment company whose historical business model centered on recurring patient support at home. For investors, the key point is that Apria built a specialized platform around respiratory therapy, sleep therapy, non-invasive ventilation, home medical equipment, specialty pharmacy services, and negative pressure wound therapy. In practice, the company operated along the post-acute and chronic-care continuum, serving patients outside the hospital and supporting physicians, payors, and patients with equipment, education, clinical monitoring, and replenishment services. Apria’s model has been structurally attractive because home-based care benefits from aging demographics, higher prevalence of chronic respiratory conditions, and payer pressure to shift care to lower-cost settings. The company stated that it had approximately 280 branch locations across the United States, giving it a nationwide footprint with local patient coverage. Its headquarters are in Indianapolis, Indiana, United States. Apria also emphasized extensive Medicare experience and one of the largest networks of payor contracts in its market, which is important in a reimbursement-driven industry where contracting strength and operating execution are critical. Historically, Apria operated as Apria Healthcare Group before its 2021 public listing, and the company then became part of a broader sector consolidation trend. The most significant recent corporate event was its acquisition by Owens & Minor, which was completed in March 2022; as a result, Apria is no longer an independent listed equity on NYSE/NASDAQ, even though it remains relevant as a brand and operating platform within a larger healthcare services group. Competitively, Apria stood out through its scale in home respiratory care, its logistics capabilities for consumable supplies, and its ability to coordinate ongoing therapy management rather than just delivering equipment once. Its customer proposition relied on clinical support, patient satisfaction, and reimbursement expertise, all of which are central in a highly regulated U.S. market. For SEO and investor context, the company should be viewed as a United States healthcare services provider with a defensive profile, a specialized home-care offering, and a history shaped by M&A-driven industry consolidation.